Question

一段医学英文翻译成中文，谢谢

Although VAS pain scores and pain relief were not found to be
significantly affected by treatment with the Lidoderm™ Patch during the first 2
treatment sessions, there was a trend by Session 2 in the intergroup
differences for both of these parameters (p=0.1075 and 0.1669, respectively),
which developed into a statistically significant difference in pain relief
(23.8%) for the Lidoderm™ Patch treatment group (2.6 vs 2.1, p=.0227) as compared
to the placebo patch after the 21-28 day period of home usage. No significant
difference in VAS pain scores were noted for the Lidoderm™ Patch and placebo
patch-treated patients during the home-use phase of the study (21-day average:
44.9 vs 47.1, p=05364), nor were there any differences seen at the end of the
home-use phase (Session 3: 37.7 vs 40.8, p=0.3708).

Answer 1

虽然血管疼痛分数和缓解疼痛没有发现
显著地受到治疗的Lidoderm™补丁在第一次2
治疗过程中,有一个趋势,会话2组间
对于这些参数差异(p = 0.1075和0.1669,分别),
发展为一个统计上的显著差异在缓解疼痛吗
(23.8%)的Lidoderm™贴片治疗组(2.6 vs 2.1,p = .0227)相比
安慰剂第21至28天期后的补丁的家庭使用。没有明显的
不同的血管疼痛分数还提到了Lidoderm™的补丁和安慰剂
患者在治疗补丁家用阶段的研究(21天的平均:
44.9 vs 47.1,p = 05364),也没有看到尽头的差异的
家用阶段(会话3:37.7 vs 40.8,p = 0.3708)。

Answer 2

虽然VAS疼痛评分和疼痛没有被发现
显着的影响，在治疗的前2™Lidoderm补丁中
治疗期间，有2组间的会话的趋势
对于这些参数的差异（P = 0.1075和0.1669，分别），
发展到疼痛差异有统计学意义
（23.8%）为™Lidoderm补丁治疗组（2.6 vs 2.1，P =。0227）相比
对安慰剂贴片后21-28天家里使用的。没有显着的
在VAS疼痛评分差异的Lidoderm补丁和安慰剂™指出
贴片治疗患者家庭使用期（21天平均：
44.9比47.1，P = 05364），也没有任何差异，看到在年底有
家庭使用的相位（3：37.7比40.8，P = 0.3708）。